Your browser doesn't support javascript.
loading
[Advances in tumor chemo-resistance regulated by MicroRNA].
Lin, Gaoyang; Xu, Ke.
Afiliación
  • Lin G; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, 
Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Xu K; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, 
Tianjin Medical University General Hospital, Tianjin 300052, China.
Zhongguo Fei Ai Za Zhi ; 17(10): 741-9, 2014 Oct 20.
Article en Zh | MEDLINE | ID: mdl-25342041
Chemotherapy is one of the primary treatment for malignant tumors. Tumor multidrug resistance (MDR) is a major cause of clinical failure of chemotherapy; however the mechanisms of chemo-resistance have not been fully elucidated. Recently, microRNA is one of the new hotspots in life science. MicroRNA regulates the expression of genes and plays roles a series of life events by post-transcriptional regulations, including cell proliferation, apoptosis, fat metabolism, nervous development, hormone secretion, tumor vessels generation, stem cell differentiation, tumor cell invasion and metastasis, and other physiological and pathological processes. Recent studies show that microRNA regulates the expression of multiple genes with high efficiency and specificity. The abnormal regulation of target genes by microRNA is responsible for tumor chemo-resistance, this may be an important component of the complexity of the regulation of chemo-resistance. Therefore, the study of microRNA and tumor drug resistance has profound practical significance. In this review, recent studies of tumor drug resistance, regulation of tumor drug resistance by microRNA, and microRNA as a potential target for tumor drug resistance therapy are reviewed.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / MicroARNs / Neoplasias Límite: Animals / Humans Idioma: Zh Revista: Zhongguo Fei Ai Za Zhi Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / MicroARNs / Neoplasias Límite: Animals / Humans Idioma: Zh Revista: Zhongguo Fei Ai Za Zhi Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: China